Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02803957 · ClinicalTrials.gov registry record · NA
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
A NA study of Mitral Valve Insufficiency, sponsored by NeoChord.
- Recruiting
- Registry status
- NA
- Development phase
- 585
- Enrollment target
- 18
- Study locations
NCT02803957: Recruiting NA study of Mitral Valve Insufficiency, sponsored by NeoChord.
NCT02803957 is a NA study of Mitral Valve Insufficiency that is actively recruiting participants, run by NeoChord. The registered enrollment target is 585 participants, above the 333-participant average among 11 other Mitral Valve Insufficiency trials with a reported enrollment target (76% higher). The trial reports 18 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02803957, a NA study of Mitral Valve Insufficiency, is actively recruiting participants, sponsored by NeoChord.
- RECRUITING
- Registry status
- NA
- Development phase
- 585 participants
- Enrollment target
- 18
- Study locations
Study Summary
The objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair using standard surgical techniques with cardiopulmonary bypass (control group).
Conditions Studied
Interventions
- DEVICE NeoChord DS1000
- DEVICE Surgical Mitral Valve Repair
Study Locations (18)
California
- Sutter Health/Alta Bates Summitt Medical Center - Oakland
- Mercy General Hospital - Sacramento
- Stanford University - Stanford
Pennsylvania
- Pinnacle Health - Harrisburg
- Penn State Milton S. Hershey Medical Center - Hershey
- University of Pittsburgh Medical Center - Pittsburgh
New York
- Mount Sinai, Icahn School of Medicine - New York
- Columbia University Medical Center - New York
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Florida
- Florida Hospital - Orlando
Georgia
- Piedmont Heart Institute - Atlanta
Indiana
- Franciscan Health - Indianapolis
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2016-11-03 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT02803957 shows while recruiting
NCT02803957 is an interventional study that assigns participants to a tested intervention. The registered 585 participants enrollment target is mid-sized for trials with a published cap, above the 333-participant average among 11 other Mitral Valve Insufficiency trials with a reported enrollment target (76% higher).
The record links to 1 condition, with Mitral Valve Insufficiency appearing as the primary indexed condition, and to 2 interventions - of which NeoChord DS1000 is the first listed.
NCT02803957 lists 18 locations in 13 states (California, Pennsylvania, New York).
Frequently Asked Questions
What is clinical trial NCT02803957 about?
NCT02803957 is a clinical study titled "Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair". The objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair using standard surgica...
What is the current status of trial NCT02803957?
This trial is currently recruiting. It is a NA study. The enrollment target is 585 participants. The study started on 2016-11-03. Estimated completion is 2027-07.
What conditions does trial NCT02803957 study?
This clinical trial studies the following conditions: Mitral Valve Insufficiency.
What interventions are being tested in trial NCT02803957?
The interventions under investigation include: NeoChord DS1000 (DEVICE), Surgical Mitral Valve Repair (DEVICE).
Who is sponsoring clinical trial NCT02803957?
This trial is sponsored by NeoChord, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02803957 being conducted?
This trial has 18 study locations across California, District of Columbia, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Valve Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02803957's enrollment target sits among peer trials
585 3rd of 11 higher than 9 of 11 other Mitral Valve Insufficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mitral Valve Insufficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study
RECRUITING · NA
-
The ENCIRCLE Trial
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
-
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
ACTIVE NOT RECRUITING · NA
-
PARTNER 3 Trial - Mitral Valve in Valve
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06680869 · 585 participants · Phase 3
Early Amiodarone in Shockable Cardiac Arrest
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
- NCT06183281 · 586 participants · NA
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI